Alerts will be sent to your verified email
Verify EmailAAREYDRUGS
Aarey Drugs & Pharma
|
Natural Capsules
|
Alpa Lab
|
|
---|---|---|---|
Operational Metrics
|
|||
Financials
|
|||
5 yr Average ROE
|
5.07 % | 9.1 % | 8.11 % |
5yr average Equity Multiplier
|
2.28 | 1.91 | 1.24 |
5yr Average Asset Turnover Ratio
|
1.56 | 0.61 | 0.66 |
5yr Avg Net Profit Margin
|
1.44 % | 6.68 % | 10.22 % |
Price to Book
|
1.55 | 1.09 | 1.16 |
P/E
|
51.41 | 0.0 | 7.59 |
5yr Avg Cash Conversion Cycle
|
77.34 Days | 25.72 Days | 119.67 Days |
Inventory Days
|
20.31 Days | 27.47 Days | 52.46 Days |
Days Receivable
|
172.65 Days | 125.88 Days | 147.5 Days |
Days Payable
|
98.9 Days | 118.63 Days | 97.89 Days |
5yr Average Interest Coverage Ratio
|
4.14 | 7.96 | 75.25 |
5yr Avg ROCE
|
8.93 % | 10.02 % | 10.84 % |
5yr Avg Operating Profit Margin
|
1.54 % | 14.83 % | 7.49 % |
5 yr average Debt to Equity
|
0.21 | 0.51 | 0.02 |
5yr CAGR Net Profit
|
-4.17 % | -38.15 % | 55.43 % |
5yr Average Return on Assets
|
2.26 % | 4.68 % | 6.5 % |
Shareholdings
|
|||
Promoter Holding
|
44.8 % | 51.26 % | 57.29 % |
Share Pledged by Promoters
|
0.0 | 0.0 | 0.0 |
Change in Promoter Holding (3 Yrs)
|
-5.23 % | -5.31 % | 0.0 |
Change in Mutual Fund Holding (3 Yrs)
|
0.0 | 0.0 | 0.0 |
Aarey Drugs & Pharma
|
Natural Capsules
|
Alpa Lab
|
|
---|---|---|---|
Product Wise Break-Up
|
Product Wise Break-Up
|
Product Wise Break-Up
|
-
|